期刊文献+

可溶性转铁蛋白受体在小儿地中海贫血诊断中的价值 被引量:4

原文传递
导出
摘要 转铁蛋白受体(transferring receptor,TfR)是一种跨膜糖蛋白,存在于大多数细胞表面,正常情况下,细胞内铁代谢所需的铁离子需经过TfR进行转运.血清可溶性TfR(sTfR)是循环于血清中的TfR胞外片段的一种形式,与机体组织铁需求相关,组织缺铁时sTfR水平可反映骨髓红细胞生成过程中缺铁的程度,患者sTfR水平越高缺铁越严重,因此目前sTfR主要用于缺铁性贫血(IDA)的诊断.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2010年第4期266-269,共4页 Chinese Journal of Hematology
  • 相关文献

参考文献8

二级参考文献69

  • 1周远青,梁瑞莲,梁玉全.利用反向斑点杂交技术检测β-地中海贫血基因突变[J].现代临床医学生物工程学杂志,2004,10(4):339-340. 被引量:3
  • 2周玉球,徐湘民.中国人β地中海贫血的分子基础及产前诊断[J].国外医学(遗传学分册),1995,18(3):132-137. 被引量:98
  • 3曾瑞萍,胡彬,金龙金.广东地区血红蛋白H病基因型分析及高危胎儿基因诊断[J].中华医学遗传学杂志,1996,13(5):266-268. 被引量:69
  • 4廖清奎.小儿缺铁性贫血诊断标准和防治建议[J].中华儿科杂志,1989,27(3):159-160.
  • 5[1]Lawrence CM, Ray S,Babyonyshev M, et al. Crystal structure of the ectodomain of human transferrin receptor [J]. Science, 1999, 286(5440) :779-782.
  • 6[2]Bzdega T, Turi T, Wroblewska B, et al. Molecular cloning of a peptidase against N-acetylaspartylglutamate from a rat hippocampal cDNA library [J]. J Neurochem, 1997,69 (6): 2270-2277.
  • 7[3]Rutledge EA, Enns CA. Cleavage of the transferrin receptor is influenced by the composition of the O-linked carbohydrate at position 104[J]. J Cell Physiol, 1996,168(2): 284-293.
  • 8[4]Gross CN,Irrinki A,Feder JN.Enns CA:Co-trafficking of HFE,a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellulariron regulation [J]. J Biol Chem, 1998,273(34) :22068-22074.
  • 9[5]Roy CN,Carlson EJ,Anderson EL, et al.Interactions of the ectodomain of HFE with the transferrin receptorare critical for iron homeostasis in cells[J] .FEBS Lett,2000,484(3) :271-274.
  • 10[6]Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2:a new member of the transferrin receptor-like family[J]. J Biol Chem, 1999,274(30) :20826-20832.

共引文献86

同被引文献42

  • 1甄学慧,王义,洪梅,李玉波.多糖铁复合物(PIC)用于妊娠缺铁性贫血的疗效观察[J].中国妇幼保健,2005,20(21):2833-2834. 被引量:18
  • 2何丹鸿,袁曦,林功舟,陈玮.多糖铁复合物微丸中铁离子的含量测定[J].中国医院药学杂志,2006,26(1):107-108. 被引量:13
  • 3张惠中.口服补铁剂多糖铁复合物[J].中国药师,2006,9(8):756-757. 被引量:15
  • 4Rosenfeld S. Follmann D. Nunez O. et al. Guidelines for the diagnosis and management of aplastic anaemia. BrJ Haematol , 2009. 147:43-70.
  • 5Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study. Blood. 1987,70: 1718-1721.
  • 6Camitta BM. Thomas ED. Nathan DG. et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976,48: 63-70.
  • 7Bacigalupo A. HowsJ. Gluckman E. et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. BrJ Haematol, 1988,70: 177-182.
  • 8MaciejewskiJP, Risitano A. Hematopoietic stem cells in aplastic anemia. Arch Med Res, 2003. 34: 520-527.
  • 9Speeckaert MM. Speeckaert R. DelangheJR. Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci. 2010. 47: 213-228.
  • 10Skikne BS. Serum transferrin receptor. AmJ Hematol, 2008. 83: 872-875.

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部